<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>2707</number>
    <updateDate>2024-12-21T09:05:24Z</updateDate>
    <updateDateIncludingText>2024-12-21T09:05:24Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <originChamberCode>H</originChamberCode>
    <type>HR</type>
    <introducedDate>2023-04-19</introducedDate>
    <congress>118</congress>
    <cdata>
      <constitutionalAuthorityStatementText>&lt;pre&gt;[Congressional Record Volume 169, Number 65 (Wednesday, April 19, 2023)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Mr. CARTER of Georgia:H.R. 2707.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8 of the ConstitutionThe single subject of this legislation is:To mitigate drug shortages and provide incentives formaintaining, expanding, and relocating the manufacturing ofactive pharmaceutical ingredients, excipients, medicaldiagnostic devices, pharmaceuticals, and personal protectiveequipment in the United States, and for other purposes.[Page H1887]&lt;/pre&gt;</constitutionalAuthorityStatementText>
    </cdata>
    <committees>
      <item>
        <systemCode>hswm00</systemCode>
        <name>Ways and Means Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <subcommittees>
          <item>
            <systemCode>hswm02</systemCode>
            <name>Health Subcommittee</name>
            <activities>
              <item>
                <name>Referred to</name>
                <date>2024-12-17T15:25:22Z</date>
              </item>
            </activities>
          </item>
        </subcommittees>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2023-04-19T14:01:50Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <actions>
      <item>
        <actionDate>2024-12-17</actionDate>
        <committees>
          <item>
            <systemCode>hswm02</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2023-04-19</actionDate>
        <text>Referred to the House Committee on Ways and Means.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hswm00</systemCode>
            <name>Ways and Means Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2023-04-19</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2023-04-19</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>C001103</bioguideId>
        <fullName>Rep. Carter, Earl L. "Buddy" [R-GA-1]</fullName>
        <firstName>Earl</firstName>
        <lastName>Carter</lastName>
        <party>R</party>
        <state>GA</state>
        <middleName>L. "Buddy"</middleName>
        <district>1</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>S001200</bioguideId>
        <fullName>Rep. Soto, Darren [D-FL-9]</fullName>
        <firstName>Darren</firstName>
        <lastName>Soto</lastName>
        <party>D</party>
        <state>FL</state>
        <district>9</district>
        <sponsorshipDate>2023-04-19</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>M001205</bioguideId>
        <fullName>Rep. Miller, Carol D. [R-WV-1]</fullName>
        <firstName>Carol</firstName>
        <lastName>Miller</lastName>
        <party>R</party>
        <state>WV</state>
        <middleName>D.</middleName>
        <district>1</district>
        <sponsorshipDate>2023-04-19</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>C001090</bioguideId>
        <fullName>Rep. Cartwright, Matt [D-PA-8]</fullName>
        <firstName>Matt</firstName>
        <lastName>Cartwright</lastName>
        <party>D</party>
        <state>PA</state>
        <district>8</district>
        <sponsorshipDate>2023-04-19</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>H001067</bioguideId>
        <fullName>Rep. Hudson, Richard [R-NC-9]</fullName>
        <firstName>Richard</firstName>
        <lastName>Hudson</lastName>
        <party>R</party>
        <state>NC</state>
        <district>9</district>
        <sponsorshipDate>2023-04-19</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>B001257</bioguideId>
        <fullName>Rep. Bilirakis, Gus M. [R-FL-12]</fullName>
        <firstName>Gus</firstName>
        <lastName>Bilirakis</lastName>
        <party>R</party>
        <state>FL</state>
        <middleName>M.</middleName>
        <district>12</district>
        <sponsorshipDate>2023-04-19</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>G000568</bioguideId>
        <fullName>Rep. Griffith, H. Morgan [R-VA-9]</fullName>
        <firstName>H.</firstName>
        <lastName>Griffith</lastName>
        <party>R</party>
        <state>VA</state>
        <middleName>Morgan</middleName>
        <district>9</district>
        <sponsorshipDate>2023-04-19</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>B001306</bioguideId>
        <fullName>Rep. Balderson, Troy [R-OH-12]</fullName>
        <firstName>Troy</firstName>
        <lastName>Balderson</lastName>
        <party>R</party>
        <state>OH</state>
        <district>12</district>
        <sponsorshipDate>2023-04-19</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>V000133</bioguideId>
        <fullName>Rep. Van Drew, Jefferson [R-NJ-2]</fullName>
        <firstName>Jefferson</firstName>
        <lastName>Van Drew</lastName>
        <party>R</party>
        <state>NJ</state>
        <district>2</district>
        <sponsorshipDate>2023-04-19</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>C001087</bioguideId>
        <fullName>Rep. Crawford, Eric A. "Rick" [R-AR-1]</fullName>
        <firstName>Eric</firstName>
        <lastName>Crawford</lastName>
        <party>R</party>
        <state>AR</state>
        <middleName>A. "Rick"</middleName>
        <district>1</district>
        <sponsorshipDate>2023-04-19</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>H001086</bioguideId>
        <fullName>Rep. Harshbarger, Diana [R-TN-1]</fullName>
        <firstName>Diana</firstName>
        <lastName>Harshbarger</lastName>
        <party>R</party>
        <state>TN</state>
        <district>1</district>
        <sponsorshipDate>2023-04-19</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>L000600</bioguideId>
        <fullName>Rep. Langworthy, Nicholas A. [R-NY-23]</fullName>
        <firstName>Nicholas</firstName>
        <lastName>Langworthy</lastName>
        <party>R</party>
        <state>NY</state>
        <middleName>A.</middleName>
        <district>23</district>
        <sponsorshipDate>2023-04-19</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>J000304</bioguideId>
        <fullName>Rep. Jackson, Ronny [R-TX-13]</fullName>
        <firstName>Ronny</firstName>
        <lastName>Jackson</lastName>
        <party>R</party>
        <state>TX</state>
        <district>13</district>
        <sponsorshipDate>2023-05-23</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>R000609</bioguideId>
        <fullName>Rep. Rutherford, John H. [R-FL-5]</fullName>
        <firstName>John</firstName>
        <lastName>Rutherford</lastName>
        <party>R</party>
        <state>FL</state>
        <middleName>H.</middleName>
        <district>5</district>
        <sponsorshipDate>2024-01-17</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects/>
      <policyArea>
        <name>Health</name>
        <updateDate>2023-04-27T18:45:59Z</updateDate>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2023-04-19</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2023-11-29T18:52:27Z</updateDate>
        <cdata>
          <text>&lt;p&gt;&lt;b&gt;Manufacturing API, Drugs, and Excipients in America Act or the MADE in America Act&lt;/b&gt;&lt;/p&gt; &lt;p&gt;This bill establishes a tax credit for certain manufacturers of pharmaceuticals or medical products.&lt;/p&gt; &lt;p&gt;Specifically, the bill establishes a tax credit for manufacturers of pharmaceuticals, active pharmaceutical ingredients, excipients (i.e., inactive ingredients), medical diagnostic devices, or personal protective equipment, if they are located in a designated distressed zone. The tax credit is equal to 25% of the manufacturer's production expenditures; the credit increases to 30% of expenditures if a substantial portion of the manufacturer's employees reside in a distressed zone. &lt;/p&gt; &lt;p&gt;The bill defines &lt;i&gt;distressed zone &lt;/i&gt;as an area that has been designated as a qualified opportunity zone by the Internal Revenue Service (i.e., an economically distressed community in which certain new investments may be eligible for preferential tax treatment) and that has a poverty rate of over 30%.&lt;/p&gt;</text>
        </cdata>
      </summary>
    </summaries>
    <title>MADE in America Act</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <titleTypeCode>45</titleTypeCode>
        <title>MADE in America Act</title>
        <updateDate>2024-07-24T15:22:38Z</updateDate>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <titleTypeCode>101</titleTypeCode>
        <title>MADE in America Act</title>
        <updateDate>2024-05-24T13:40:48Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <titleTypeCode>101</titleTypeCode>
        <title>Manufacturing API, Drugs, and Excipients in America Act</title>
        <updateDate>2024-05-24T13:40:48Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <titleTypeCode>6</titleTypeCode>
        <title>To mitigate drug shortages and provide incentives for maintaining, expanding, and relocating the manufacturing of active pharmaceutical ingredients, excipients, medical diagnostic devices, pharmaceuticals, and personal protective equipment in the United States, and for other purposes.</title>
        <updateDate>2024-03-18T20:38:40Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2023-04-19T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-118hr2707ih/xml/BILLS-118hr2707ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2024-12-17</actionDate>
      <text>Referred to the Subcommittee on Health.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
